Nyame, Kwamina https://orcid.org/0000-0001-8898-4689
Xiong, Jian https://orcid.org/0000-0001-9008-3134
Alsohybe, Hisham N. https://orcid.org/0009-0002-3277-8821
de Jong, Arthur P. H. https://orcid.org/0000-0002-7620-2704
Peña, Isabelle V.
de Miguel, Ricardo https://orcid.org/0000-0001-8732-9076
Brummelkamp, Thijn R. https://orcid.org/0000-0002-3066-7071
Hartmann, Guido
Nijman, Sebastian M. B. https://orcid.org/0000-0003-0464-6661
Raaben, Matthijs
Simcox, Judith A.
Blomen, Vincent A.
Abu-Remaileh, Monther https://orcid.org/0000-0003-3772-0477
Article History
Received: 17 May 2024
Accepted: 25 March 2025
First Online: 7 May 2025
Competing interests
: M.A.-R. is a scientific advisory board member of Lycia Therapeutics and senior advisor of Scenic Biotech. M.R., V.A.B., S.M.B.N., T.R.B., A.P.H.d.J. and G.H. are employees or advisors of Scenic Biotech. R.d.M. is an employee of AnaPath Services. The other authors declare no competing interests.